mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.8 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |